Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of permanent pacemaker requirement after transcatheter aortic valve implantation: insights from a Brazilian registry.
Gensas CS, Caixeta A, Siqueira D, Carvalho LA, Sarmento-Leite R, Mangione JA, Lemos PA, Colafranceschi AS, Caramori P, Ferreira MC, Abizaid A, Brito FS Jr; Brazilian Registry in Transcatheter Aortic Valve Implantation Investigators. Gensas CS, et al. Among authors: siqueira d. Int J Cardiol. 2014 Aug 1;175(2):248-52. doi: 10.1016/j.ijcard.2014.05.020. Epub 2014 May 16. Int J Cardiol. 2014. PMID: 24880480
[Relationship between plasma C-reactive protein level and neointimal hyperplasia volume in patients with zotarolimus-eluting stents. Volumetric analysis by three-dimensional intracoronary ultrasound].
Lasave LI, Abizaid AA, Paiva e Maia J, de Ribamar Costa J Jr, Feres F, Mattos LA, Abizaid AS, Siqueira DA, Tanajura LF, Staico R, Beraldo de Andrade P, Braga SN, Sousa AG, Sousa JE. Lasave LI, et al. Rev Esp Cardiol. 2007 Sep;60(9):923-31. doi: 10.1157/13109645. Rev Esp Cardiol. 2007. PMID: 17915148 Free article. Spanish.
Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system.
Costa JR Jr, Abizaid A, Costa R, Feres F, Tanajura LF, Abizaid A, Mattos LA, Staico R, Siqueira D, Sousa AG, Bonan R, Sousa JE. Costa JR Jr, et al. Among authors: siqueira d. JACC Cardiovasc Interv. 2008 Oct;1(5):545-51. doi: 10.1016/j.jcin.2008.07.003. JACC Cardiovasc Interv. 2008. PMID: 19463357 Free article.
1-year results of the hydroxyapatite polymer-free sirolimus-eluting stent for the treatment of single de novo coronary lesions: the VESTASYNC I trial.
Costa JR Jr, Abizaid A, Costa R, Feres F, Tanajura LF, Abizaid A, Maldonado G, Staico R, Siqueira D, Sousa AG, Bonan R, Sousa JE. Costa JR Jr, et al. Among authors: siqueira d. JACC Cardiovasc Interv. 2009 May;2(5):422-7. doi: 10.1016/j.jcin.2009.02.009. JACC Cardiovasc Interv. 2009. PMID: 19463465 Free article.
159 results